U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07696182) titled 'Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR' on July 06.

Brief Summary: VOYAGER CE Clinical Study using the Encantor TAVI System.

Study Start Date: Nov. 30, 2026

Study Type: INTERVENTIONAL

Condition: Severe Native Calcific Aortic Stenosis Symptomatic Heart Disease Due to Severe Native Calcific Aortic Stenosis

Intervention: DEVICE: Prospective, single-arm, multi-center study.

This intervention is distinguished by the use of the Encantor TAVI System, a transcatheter valve replacement therapy specifically designed for patients with symptomatic severe native calcific aortic stenosis ...